BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21652096)

  • 1. Evidence for a role of advanced glycation end products in atrial fibrillation.
    Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Seoane-Blanco A; Moure-González M; Varela-Román A; Álvarez E; González-Juanatey JR
    Int J Cardiol; 2012 Jun; 157(3):397-402. PubMed ID: 21652096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High plasma level of soluble RAGE is independently associated with a low recurrence of atrial fibrillation after catheter ablation in diabetic patient.
    Yang PS; Kim TH; Uhm JS; Park S; Joung B; Lee MH; Pak HN
    Europace; 2016 Nov; 18(11):1711-1718. PubMed ID: 26838688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation.
    Lancefield TF; Patel SK; Freeman M; Velkoska E; Wai B; Srivastava PM; Horrigan M; Farouque O; Burrell LM
    PLoS One; 2016; 11(9):e0161715. PubMed ID: 27627677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes.
    Su XD; Li SS; Tian YQ; Zhang ZY; Zhang GZ; Wang LX
    Arch Med Res; 2011 Oct; 42(7):596-601. PubMed ID: 22100610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease.
    Bakker SF; Tushuizen ME; Gözütok E; Çiftci A; Gelderman KA; Mulder CJ; Simsek S
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):230-5. PubMed ID: 25467215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of soluble receptor for advanced glycation end-product with increasing central aortic stiffness in hypertensive patients.
    Yoon SJ; Park S; Park C; Chang W; Cho DK; Ko YG; Choi D; Kwon HM; Jang Y; Chung N
    Coron Artery Dis; 2012 Mar; 23(2):85-90. PubMed ID: 22198512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
    Basta G; Castagnini M; Del Turco S; Epistolato MC; Righini P; Sangiorgi GM; De Caterina R; Tanganelli P
    Eur J Clin Invest; 2009 Dec; 39(12):1065-72. PubMed ID: 19811526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.
    Kato T; Yamashita T; Sekiguchi A; Tsuneda T; Sagara K; Takamura M; Kaneko S; Aizawa T; Fu LT
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):415-20. PubMed ID: 18298515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
    Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
    PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrillation.
    Deng H; Xue YM; Zhan XZ; Liao HT; Guo HM; Wu SL
    Chin Med J (Engl); 2011 Jul; 124(13):1976-82. PubMed ID: 22088456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.
    Prasad K
    Int J Angiol; 2020 Jun; 29(2):72-80. PubMed ID: 32476808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
    Norata GD; Garlaschelli K; Grigore L; Tibolla G; Raselli S; Redaelli L; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):129-34. PubMed ID: 18595673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
    Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
    J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.
    Wang P; Huang R; Lu S; Xia W; Cai R; Sun H; Wang S
    PLoS One; 2016; 11(1):e0145521. PubMed ID: 26745632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
    Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
    Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.
    Al Rifai M; Schneider AL; Alonso A; Maruthur N; Parrinello CM; Astor BC; Hoogeveen RC; Soliman EZ; Chen LY; Ballantyne CM; Halushka MK; Selvin E
    J Diabetes Complications; 2015 Mar; 29(2):180-5. PubMed ID: 25499973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.